Publications
Print PDF
U.S. Government Accuses Gilead of Infringing HIV-Prevention Drug Regimen Patents
November 8, 2019
Thomas Long
IP Law Daily

Axinn partner Chad Landmon was quoted in the IP Law Daily article, "U.S. Government Accuses Gilead of Infringing HIV-Prevention Drug Regimen Patents."

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.